华中科技大学学报(医学英德文版)
華中科技大學學報(醫學英德文版)
화중과기대학학보(의학영덕문판)
JOURNAL OF TONGJI MEDICAL UNIVERSITY
2002年
1期
14-16
,共3页
顾世芬%陈汇%邱应海%师少军%曾繁典
顧世芬%陳彙%邱應海%師少軍%曾繁典
고세분%진회%구응해%사소군%증번전
irbesartan%pharmacokinetics%bioavailability%HPLC
The pharmacokinetics and relative bioavailability were studied in 18 healthy volunteers. A single oral dose of 150 mg irbesartan capsule (test) or tablet (reference) was given to each volunteer according to a randomized 2-way crossover study. The concentrations in plasma were determined by HPLC-UV method. The main parameters of irbesartan capsules were: Cmax: 1. 502± 0. 295 μg/ml,tmax: 1. 44±0. 34 h, t1/2: 20. 21±14. 71 h, AUC0-t: 11. 087t3.443 μg/ml-1·h. The relative bioavailability of capsule to tablet was (101.4±28.9) %. The results of statistical analysis showed that two formulations were hioequivalent.
